ASX:RSH - Respiri Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Respiri Limited Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Today's Range N/A50-Day Range N/A52-Week Range N/AVolume1.19 million shsAverage VolumeN/AMarket Capitalization$41.16 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Respiri Limited, a health technology company, researches, develops, and commercializes, medical devices in Australia and Israel. The company produces and sells mobile health applications. Its products include Wheezo, a mobile app, which has asthma management diary, medication usage and reminders, and symptoms and triggers to help asthma sufferers; Wholter, a device for home ambulatory recording of nocturnal wheeze and cough; and AirSonea, a digital stethoscope that is paired to a smartphone app to record breathing sounds accurately. The company also offers PulmoTrack, a computerized wheeze detection product designed for hospital/clinical based real-time monitoring of wheeze and cough in the management of acute asthma in the ER and ICU, and for pediatric pulmonary function testing and sleep labs; and SonoSentry, an over-the-counter wheeze-detection device. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited was incorporated in 1987 and is based in Melbourne, Australia.Read More Industry, Sector and Symbol Stock Exchange ASX Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolASX:RSH Previous Symbol CUSIPN/A CIKN/A Webhttp://www.respiri.co/ Phone61 3 9602 3366Debt Debt-to-Equity RatioN/A Current Ratio0.75 Quick Ratio0.70Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$2.16 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow37.00 Book ValueA$0.00 per share Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares556,257,984Market Cap$41.16 million Next Earnings DateN/A OptionableNot Optionable Receive RSH News and Ratings via Email Sign-up to receive the latest news and ratings for RSH and its competitors with MarketBeat's FREE daily newsletter. Respiri (ASX:RSH) Frequently Asked Questions Has Respiri been receiving favorable news coverage? News headlines about RSH stock have trended very positive on Sunday, according to InfoTrie. The research firm identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Respiri earned a media sentiment score of 4.0 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near term. View the latest news aboutRespiri. Who are some of Respiri's key competitors? Some companies that are related to Respiri include Hamilton Thorne (HTL), Medica Group (MGP), Electromed (ELMD), Cyclopharm (CYC), Electromed (ELMD), Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB (IMR), REVA Medical (RVA), Advanced Oncotherapy (AVO), Patient Home Monitoring (PTQ), Protech Home Medical (PHM), MRI Interventions (MRIC), Oventus Medical (OVN), Kromek Group (KMK), Resonance Health (RHT) and Avacta Group (AVCT). Who are Respiri's key executives? Respiri's management team includes the following people: Ms. Koswani Wall, Chief Customer Experience & Communications OfficerDr. Samaneh Sarraf Shirazi, Chief Research OfficerMr. Nicholas Smedley, Exec. ChairmanMr. Marjan Mikel, CEO & DirectorMs. Jan P. Barker, Vice-Pres of Bus. Devel. What is Respiri's stock symbol? Respiri trades on the ASX under the ticker symbol "RSH." How big of a company is Respiri? Respiri has a market capitalization of $0.00 and generates $2.16 million in revenue each year. View additional information about Respiri. What is Respiri's official website? The official website for Respiri is http://www.respiri.co/. How can I contact Respiri? The company can be reached via phone at 61 3 9602 3366. MarketBeat Community Rating for Respiri (ASX RSH)Community Ranking: 2.1 out of 5 ( )Outperform Votes: 3 (Vote Outperform)Underperform Votes: 4 (Vote Underperform)Total Votes: 7MarketBeat's community ratings are surveys of what our community members think about Respiri and other stocks. Vote "Outperform" if you believe RSH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RSH will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/29/2020 by MarketBeat.com StaffFeatured Article: Bar Chart
